Status:
COMPLETED
Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560
Lead Sponsor:
Mayo Clinic
Conditions:
Vestibular Schwannoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to see if there is benefit to using an IV contrast called AK-Fluor® and a microscope filter called YELLOW560 when surgically removing a vestibular schwannoma, Meningioma, ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patient with a suspected VS
- Recurrent VS with prior microsurgical resection or radiation therapy
- Clinical indication for microsurgical resection
- Exclusion Criteria
- History of allergy to FS
- History of renal failure
- Pregnant women
- Those with inability to give informed consent
- Prisoners and inmates
Exclusion
Key Trial Info
Start Date :
October 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04351373
Start Date
October 6 2021
End Date
May 25 2022
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905